This company listing is no longer active
Home Point Capital Valuation
Is 786 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 786 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 786's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 786's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 786?
Key metric: As 786 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 786's PS Ratio? | |
|---|---|
| PS Ratio | 3.7x |
| Sales | US$86.78m |
| Market Cap | US$321.44m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 18.6x |
| Enterprise Value/EBITDA | -6.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 786's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2x | ||
PBB Deutsche Pfandbriefbank | 1.9x | 12.0% | €691.9m |
ARLN Aareal Bank | 2.3x | 10.5% | €2.0b |
ENGL EV Digital Invest | 0.7x | 9.8% | €3.0m |
VVV3 Ökoworld | 3.2x | 4.6% | €198.6m |
786 Home Point Capital | 3.7x | 39.9% | €321.4m |
Price-To-Sales vs Peers: 786 is good value based on its Price-To-Sales Ratio (3.7x) compared to the peer average (15.9x).
Price to Sales Ratio vs Industry
How does 786's PS Ratio compare vs other companies in the DE Diversified Financial Industry?
Price-To-Sales vs Industry: 786 is expensive based on its Price-To-Sales Ratio (3.7x) compared to the European Diversified Financial industry average (2.4x)
Price to Sales Ratio vs Fair Ratio
What is 786's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.7x |
| Fair PS Ratio | 1.4x |
Price-To-Sales vs Fair Ratio: 786 is expensive based on its Price-To-Sales Ratio (3.7x) compared to the estimated Fair Price-To-Sales Ratio (1.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Nov ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Oct ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Sep ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Aug ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Jul ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Jun ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| May ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Apr ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Mar ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Feb ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Jan ’25 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Dec ’24 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Nov ’24 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Oct ’24 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Sep ’24 | n/a | €1.93 0% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Aug ’24 | €2.08 | €1.93 -7.4% | 7.6% | €2.09 | €1.78 | n/a | 6 |
| Jul ’24 | €2.10 | €1.98 -5.6% | 7.6% | €2.15 | €1.83 | n/a | 6 |
| Jun ’24 | €2.14 | €1.98 -7.4% | 7.6% | €2.15 | €1.83 | n/a | 6 |
| May ’24 | €1.78 | €1.81 +1.6% | 22.0% | €2.30 | €1.15 | n/a | 7 |
| Apr ’24 | €1.94 | €1.80 -7.1% | 22.7% | €2.36 | €1.18 | n/a | 8 |
| Mar ’24 | €1.46 | €1.67 +14.5% | 25.8% | €2.33 | €1.16 | n/a | 8 |
| Feb ’24 | €1.65 | €1.67 +1.3% | 25.8% | €2.33 | €1.16 | n/a | 8 |
| Jan ’24 | €1.30 | €1.83 +40.6% | 35.8% | €3.30 | €1.18 | n/a | 8 |
| Dec ’23 | €1.49 | €2.15 +44.5% | 36.3% | €3.40 | €1.46 | n/a | 8 |
| Nov ’23 | €1.75 | €3.37 +92.7% | 23.8% | €4.07 | €1.53 | n/a | 8 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
OIX
JP¥20.40
7D
1.0%
1Y
22.2%
Exor
€20.6b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
EYX
€95.55
7D
2.9%
1Y
8.8%
Merchants Bancorp
US$1.9b
Operates as the diversified bank holding company in the United States.
3KD
US$39.00
7D
6.6%
1Y
29.1%